HEPION PHARMACEUTICALS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-31.2M | $-31.4M | $130.4K | $4.7M |
| FY2022 | $-35.0M | $-35.0M | $16.3K | $2.6M |
| FY2023 | $-40.9M | $-40.9M | $14.3K | $1.3M |
| FY2024 | $-18.2M | $-18.2M | — | $791.6K |
| FY2025 | $-3.3M | $-3.3M | — | $20.8K |